MedTrace Logo

Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)

NCT00507104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-12-14

No results posted yet for this study

Summary

This study performs assessments of pituitary functions by basal hormone levels in the acute phase after TBI and/or SAH followed by detailed endocrine tests (insulin-induced hypoglycemia or growth hormone releasing hormone-arginine-corticotropin releasing hormone-leuteinizing hormone releasing hormone \[GHRH-arginine-CRH-LHRH\] test) after 4 and 12 months.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Michael Buchfelder, M.D., Ph.D. · Department of Neurosurgery, University of Erlangen

  • Juergen Kreutzer, M.D. · Department of Neurosurgery, University of Erlangen

  • Christioph Schöfl, M.D., Ph.D. · Department of Neurosurgery, Division Neuroendocrinology, University of Erlangen

  • Andrea Kleindienst, M.D. · Department of Neurosurgery, University of Erlangen

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00507104 on ClinicalTrials.gov